Nomination committee appointed in IRLAB
In preparation for the annual general meeting 2019, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of Bo Rydlinger, Daniel Johnsson and Olle Stenberg beside Anders Vedin, the chairman of the board. The nomination committee represents almost 58 per cent of shares and votes in the company.According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB that was resolved at the annual general meeting on May 16, 2018, the nomination committee shall,